Приказ основних података о документу

dc.creatorCanullo, Luigi
dc.creatorPesce, Paolo
dc.creatorBotticelli, Daniele
dc.creatorCovani, Ugo
dc.creatorJanković, Saša
dc.creatorJovanović, Tanja
dc.creatorRakić, Mia
dc.date.accessioned2018-02-22T10:04:38Z
dc.date.available2900-01-01
dc.date.issued2018
dc.identifier.issn0882-2786
dc.identifier.urihttp://quintpub.com/journals/omi/abstract.php?iss2_id=1499&article_id=17993
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/3002
dc.description.abstractPURPOSE To compare the qualitative and quantitative profile of Epstein-Barr virus (EBV) at external and internal implant surfaces between participants with peri-implantitis and healthy peri-implant tissues and to quantitatively assess the relation between EBV and periopathogens inside the microbiologic profile associated with peri-implantitis. MATERIALS AND METHODS Microbiologic specimens were retrieved from 84 patients wearing 190 implants to estimate the levels of EBV and 10 periopathogens in the peri-implant pocket and internal-implant connection using quantitative polymerase chain reaction. RESULTS The study sample consisted of 113 healthy and 77 peri-implantitis-affected implants. Statistical significance was not reached in EBV prevalence between peri-implantitis and healthy controls. EBV-positive participants demonstrated higher levels of Prevotella intermedia (Pi) and Campylobacter rectus (Cr) compared with EBV-negative participants. A positive correlation was demonstrated among EBV and Tannerella forsythia (Tf), Parvimonas micra (Pm), Fusobacterium nucleatum (Fn), and Cr levels in peri-implantitis-affected implants, while healthy controls demonstrated a positive correlation between EBV and Aggregatibacter actinomycetemcomitans (Aa), Pi, and Pm. CONCLUSION EBV cannot be considered as a microbiologic marker of peri-implantitis. However, EBV could be considered as a risk factor and a peri-implantitis enhancer based on its positive correlations with pathogens associated with peri-implantitis.en
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41008/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173056/RS//
dc.rightsrestrictedAccess
dc.sourceThe International Journal of Oral and Maxillofacial Implants
dc.subjectCampylobacter rectus
dc.subjectEpstein-Barr virus infections
dc.subjectFusobacterium nucleatum
dc.subjectPeri-implantitis
dc.subjectPrevotella intermedia
dc.titleWhat is the Impact of Epstein-Barr Virus in Peri-implant Infection?en
dc.typearticleen
dc.rights.licenseARR
dcterms.abstractЈовановић, Тања; Цанулло, Луиги; Цовани, Уго; Ракић, Миа; Песце, Паоло; Боттицелли, Даниеле; Јанковић, Саша;
dc.rights.holder© 2018 by Quintessence Publishing Co Inc.
dc.citation.issue1
dc.citation.volume33
dc.identifier.doi10.11607/jomi.5972
dc.identifier.pmid29340343
dc.identifier.scopus2-s2.0-85041856928
dc.identifier.wos000424190000008
dc.citation.apaCanullo, L., Pesce, P., Botticelli, D., Covani, U., Jankovic, S., Jovanovic, T., & Rakic, M. (2018). What is the Impact of Epstein-Barr Virus in Peri-implant Infection? The International Journal of Oral and Maxillofacial Implants, 33(1), 58–63.
dc.citation.vancouverCanullo L, Pesce P, Botticelli D, Covani U, Jankovic S, Jovanovic T, Rakic M. What is the Impact of Epstein-Barr Virus in Peri-implant Infection? Int J Oral Maxillofac Implant. 2018;33(1):58–63.
dc.citation.spage58
dc.citation.epage63
dc.type.versionpublishedVersionen
dc.citation.rankM21


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу